U.S. Luxury Stock News

Shareholder John Chevedden has filed a proposal at Dover Corporation (NYSE: DOV) calling for an independent board chairman. The proposal seeks a formal policy that the roles of Chairman and CEO be held by different individuals. Dover's board has recommended that shareholders vote against the proposal at the upcoming annual general meeting. Dover, traded on the NYSE under the ticker DOV, operates as a diversified industrial company with exposure to equipment, components, and related...

ANI Pharmaceuticals recently reported record 2025 revenue of US$883.4 million, driven largely by strong growth in its Rare Disease segment and Cortrophin Gel, while an executive share sale on March 11, 2026 drew investor attention. The company’s guidance for more than US$1.00 billion in 2026 revenue highlights how Rare Disease therapies are becoming an increasingly central pillar of its business model. We’ll now examine how ANI Pharmaceuticals’ push past US$1.00 billion in guided 2026...

Attention around Oscar Health (OSCR) is building ahead of its forthcoming earnings release, where projections point to a significantly higher EPS than a year ago, set alongside expanding margins and rising operational efficiency. See our latest analysis for Oscar Health. Despite the upcoming earnings focus, recent trading has been weak, with a 30 day share price return showing a decline of 13.98% and a year to date share price return showing a decline of 25.58%, while the 3 year total...

In March 2026, Constellation Energy filed a definitive proxy urging shareholders to vote against a DEI-related proposal and registered up to 50,000,000 common shares, worth about US$15.86 billion, for an ESOP-related shelf offering. These moves come as Constellation deepens nuclear-focused partnerships with major technology companies and reshapes its generation portfolio following the Calpine acquisition and planned PJM asset sales. We’ll now examine how Constellation’s expanded nuclear...

SELLAS Life Sciences Group (SLS) is drawing attention after releasing preclinical data on its CDK9 inhibitor SLS009 in acute myeloid leukemia and filing both a universal shelf registration and a US$150 million at-the-market equity offering. See our latest analysis for SELLAS Life Sciences Group. Those preclinical SLS009 data and the fresh shelf and at the market filing are landing after a sharp run, with the 1 year total shareholder return near 3x and a 52.09% 90 day share price return, even...

If you are wondering whether Norwegian Cruise Line Holdings at around US$18.49 is a bargain or a value trap, this breakdown is designed to help you frame that question clearly. The stock has fallen 2.4% over the last week, 22.3% over the last month, 18.8% year to date and 3.4% over the last year, even though the three year return sits at 37.5% and the five year return at a 33.3% decline. Recent headlines have focused on the broader cruise and travel sector, with investors weighing changing...

ITT (ITT) has drawn fresh interest after recent share price swings, including an 11.6% decline over the past month and a 3.8% gain over the past 3 months, prompting closer attention to its current valuation. See our latest analysis for ITT. The recent 1-month share price return of negative 11.6% contrasts with a 6% year to date share price gain and a 1-year total shareholder return of 44.7%. This suggests that longer term momentum remains stronger than the latest pullback. If ITT’s moves have...

DLocal Limited reported past fourth-quarter and full-year 2025 results with higher sales and net income, issued 2026 operating profit growth guidance of 27.5%–32.5% year-over-year, and declared a cash dividend totaling about US$57,211,274, or roughly US$0.1939 per share, payable in June 2026. The combination of stronger profitability metrics, forward-looking profit guidance, and a sizable cash return to shareholders highlights management’s confidence in DLocal’s current earnings power and...

Karman Holdings Inc. recently reported past fourth-quarter 2025 results showing sales of US$134.49 million and net income of US$7.71 million, with full-year 2025 sales reaching US$471.50 million and net income of US$17.37 million. The company also raised its 2026 revenue outlook to US$715 million–US$730 million as its funded backlog moved beyond US$1 billion and recent acquisitions broadened its space and defense capabilities. Now, we’ll examine how the raised 2026 revenue guidance and...

CME Group (NasdaqGS:CME) has proposed an amendment to its certificate of incorporation that would eliminate special director election rights for Class B-1, B-2, and B-3 shareholders. If approved at the May 2026 Annual Meeting, the change would remove long-standing board representation privileges tied to these legacy share classes. The proposal would simplify board elections and adjust the balance of influence between Class B holders and the wider shareholder base. CME Group, a major global...

How Simpson Manufacturing is positioned after recent share moves Recent share price moves in Simpson Manufacturing (SSD), including a month return of about a 12% decline and a roughly flat past 3 months, have put the stock on many investors’ watchlists. At a recent close of US$168.38 and a market value of about US$7.1b, the company sits against a backdrop of annual revenue of US$2,332.81m and net income of US$345.08m. See our latest analysis for Simpson Manufacturing. Recent trading has been...

American Tower (AMT) is back in focus after recent share price moves, with the stock showing a one-month return of about a 7% decline and a past three-month return of roughly a 4% decline. See our latest analysis for American Tower. At a share price of $169.52, American Tower’s recent 7 day and 30 day share price returns of a 4.11% and 7.10% decline reflect a softer year to date share price return and a 1 year total shareholder return of an 18.60% decline, pointing to fading momentum as...

Federal Realty Investment Trust (FRT) is back on investor radars after recent price moves, with the stock closing at $102.87 and showing mixed returns over the past month and the past three months. See our latest analysis for Federal Realty Investment Trust. At a share price of $102.87, Federal Realty’s recent 1 day and 30 day share price declines contrast with a positive year to date share price return and solid 1 year total shareholder return. This suggests that momentum has cooled after...

Wondering if American States Water at around US$75 a share still makes sense for your portfolio, or if the price is running ahead of the fundamentals? The stock last closed at US$75.10, with returns of 3.7% over the past week, 1.2% over the past month, 3.9% year to date, and a 0.8% decline over the past year. These figures may prompt questions about how the market is currently pricing its prospects. Recent attention on regulated utilities and essential service providers has kept American...

Clearway Energy (CWEN.A) has attracted investor attention recently, with the share price around $38.93 and total returns of 21% year to date and 45% over the past year. See our latest analysis for Clearway Energy. The 23.8% 90 day share price return and 45.0% 1 year total shareholder return indicate firm momentum, suggesting investors are reassessing Clearway Energy’s growth prospects and risk profile within the clean power and grid reliability space. If you are looking beyond Clearway Energy...

Stock performance snapshot Natera (NTRA) has drawn investor attention after a period of weaker share performance, with the stock down about 7% over the past week, 14% over the past month, and 22% in the past 3 months. See our latest analysis for Natera. That weak recent share price momentum contrasts with a 26.89% 1 year total shareholder return and a very large 228.98% 3 year total shareholder return. This suggests the latest pullback may reflect shifting sentiment around growth prospects...

Why the Dimensional ETF mandate matters for State Street stock State Street (STT) has been appointed to provide end to end servicing for Dimensional Fund Advisors’ new ETF share class structure, the first arrangement of its kind approved in the U.S. under recent SEC exemptive relief. For you as an investor, this mandate highlights State Street’s role across custody, accounting, ETF basket creation, create or redeem order management, settlement, transfer agency and reporting for Dimensional’s...

What Recent Returns Suggest About Navios Maritime Partners Recent performance for Navios Maritime Partners (NMM) may catch your attention, with the unit price down about 4% over the past month but showing a gain of roughly 25% over the past 3 months. Over longer periods, total return figures of about 69% for the past year and very large gains over 3 and 5 years put the current valuation conversation front and center for income focused and total return oriented investors alike. See our latest...

Vertical Aerospace recently reported full-year 2025 results showing net income of £232.93 million, reversing the prior year's £781.24 million net loss. Alongside this financial turnaround, the company activated an automated battery pilot production line at its Vertical Energy Centre, sharpening its focus on in-house battery technology for certification and long-term recurring revenue from replacement packs. Next, we’ll examine how Vertical’s shift to profitability and new automated battery...

Comcast: Recent Performance Snapshot Comcast (CMCSA) has drawn investor attention after a period of weaker share performance, with the stock down over the past month, past 3 months, year to date and over the past year. At a recent close of $28.33, the company shows mixed fundamentals, with modest annual revenue growth alongside a decline in net income and a current market value of about $102b across its global media and connectivity operations. See our latest analysis for Comcast. For...

In March 2026, ImmunityBio faced regulatory and legal pressure as an FDA warning letter over alleged misleading Anktiva promotions was followed by a securities class action lawsuit claiming investors were misled about the drug’s capabilities and the company’s prospects. At the same time, ANKTIVA advanced clinically and commercially, with an Independent Data Monitoring Committee confirming adequate power for the pivotal QUILT-2.005 trial and new approvals and guideline recognition extending...

FTAI Aviation (FTAI) has drawn attention after recent share price swings, with a loss of about 21% over the past month, in contrast with a gain of roughly 37% in the past 3 months. See our latest analysis for FTAI Aviation. That pullback over the past month contrasts with FTAI Aviation’s stronger recent momentum, with a 7 day share price return of 3.93%, a 90 day share price return of 37.24%, and a 1 year total shareholder return of 114.59%. This suggests sentiment has cooled in the short...

On March 23, 2026, Healthpeak Properties, Inc. closed a new US$400,000,000 unsecured delayed-draw term loan facility maturing in March 2031, with interest set at SOFR plus 80 basis points and the facility undrawn at closing. The participation of major lenders such as BofA Securities, JPMorgan, and Wells Fargo Securities underscores lender confidence in Healthpeak’s balance sheet strength and financing flexibility. Next, we’ll examine how this new undrawn US$400,000,000 term loan facility...

ONEOK (OKE) has been in focus after recent analyst commentary linked geopolitical disruptions, including the Iran war, to stronger global energy demand and potentially greater use of the company’s Permian centered midstream network. See our latest analysis for ONEOK. ONEOK’s recent geopolitical tailwinds and project updates come on top of strong share price momentum, with a 30 day share price return of 14.2% and a three year total shareholder return of 73.05% indicating that interest has been...